Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.8M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$134M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Hayes Christopher G. | Aug 27, 2024 | Sell | 9,530 | $2.46 | $23,000 |
| Goldenberg Gary | Aug 27, 2024 | Sell | 3,601 | $2.46 | $8,900 |
| Bonaccorso Joe | Aug 27, 2024 | Sell | 8,993 | $2.46 | $22,000 |
| Kohler Terry | Aug 27, 2024 | Sell | 7,899 | $2.46 | $19,000 |
| White Ted | Aug 27, 2024 | Sell | 9,021 | $2.46 | $22,000 |
| Hayes Christopher G. | Aug 26, 2024 | Sell | 26,183 | $2.66 | $70,000 |
| Bonaccorso Joe | Aug 26, 2024 | Sell | 24,709 | $2.66 | $66,000 |
| Kohler Terry | Aug 26, 2024 | Sell | 21,820 | $2.66 | $58,000 |
| White Ted | Aug 26, 2024 | Sell | 24,979 | $2.66 | $66,000 |
| Goldenberg Gary | Aug 26, 2024 | Sell | 9,888 | $2.66 | $26,000 |
| White Ted | Jul 23, 2024 | Sell | 154 | $6.98 | $1,100 |
| Bonaccorso Joe | Jul 23, 2024 | Sell | 115 | $6.98 | $800 |
| Goldenberg Gary | Jul 23, 2024 | Sell | 86 | $6.98 | $600 |
| Hayes Christopher G. | Jul 23, 2024 | Sell | 91 | $6.98 | $640 |
| White Ted | Jul 22, 2024 | Sell | 32,469 | $7.06 | $230,000 |
| Bonaccorso Joe | Jul 22, 2024 | Sell | 25,461 | $7.06 | $180,000 |
| Goldenberg Gary | Jul 22, 2024 | Sell | 18,421 | $7.06 | $130,000 |
| Hayes Christopher G. | Jul 22, 2024 | Sell | 21,649 | $7.06 | $150,000 |
| EDELMAN JOSEPH | Dec 29, 2023 | Buy | 115,774 | $7.24 | $840,000 |
| EDELMAN JOSEPH | Dec 28, 2023 | Buy | 126,116 | $7.08 | $890,000 |
| EDELMAN JOSEPH | Dec 27, 2023 | Buy | 79,726 | $7.2 | $570,000 |
| EDELMAN JOSEPH | Dec 26, 2023 | Buy | 54,652 | $6.49 | $350,000 |
| EDELMAN JOSEPH | Dec 22, 2023 | Buy | 250,000 | $6.67 | $1.7M |
| EDELMAN JOSEPH | Dec 21, 2023 | Buy | 200,000 | $6.17 | $1.2M |
| EDELMAN JOSEPH | Dec 19, 2023 | Buy | 277,008 | $5.36 | $1.5M |
| EDELMAN JOSEPH | Dec 18, 2023 | Buy | 456,923 | $5.41 | $2.5M |
| EDELMAN JOSEPH | Dec 15, 2023 | Buy | 500,000 | $5.97 | $3M |
| Bonaccorso Joe | Nov 15, 2023 | Sell | 11,266 | $2.97 | $33,000 |
| White Ted | Nov 15, 2023 | Sell | 11,558 | $2.97 | $34,000 |
| Hayes Christopher G. | Nov 15, 2023 | Sell | 11,558 | $2.97 | $34,000 |
| Goldenberg Gary | Nov 15, 2023 | Sell | 3,036 | $2.97 | $9,000 |
| Kohler Terry | Nov 15, 2023 | Sell | 9,632 | $2.97 | $29,000 |
| Bonaccorso Joe | Nov 14, 2023 | Sell | 21,580 | $2.93 | $63,000 |
| Kohler Terry | Nov 14, 2023 | Sell | 18,452 | $2.93 | $54,000 |
| White Ted | Nov 14, 2023 | Sell | 22,141 | $2.93 | $65,000 |
| Hayes Christopher G. | Nov 14, 2023 | Sell | 22,141 | $2.93 | $65,000 |
| Goldenberg Gary | Nov 14, 2023 | Sell | 5,817 | $2.93 | $17,000 |
| Manning Paul B | Jul 24, 2023 | Buy | 200,000 | $5.02 | $1M |
| Hayes Christopher G. | Jul 24, 2023 | Sell | 33,789 | $4.83 | $160,000 |
| Goldenberg Gary | Jul 24, 2023 | Sell | 28,699 | $4.83 | $140,000 |
| Bonaccorso Joe | Jul 24, 2023 | Sell | 38,262 | $4.83 | $180,000 |
| White Ted | Jul 24, 2023 | Sell | 50,677 | $4.83 | $240,000 |
What's the latest insider transaction for Verrica Pharmaceuticals?
The most recent insider transaction for Verrica Pharmaceuticals was conducted by Hayes Christopher G., who sold 9,530 shares on August 27, 2024 at a price of $2.46 per share.
Which insider bought the most VRCA stock over the last two years?
EDELMAN JOSEPH has bought the most VRCA stock in the last 2 years, with a total value of $13M.
Which insider has sold the most VRCA stock over the last two years?
White Ted has sold the most VRCA stock in the last 2 years, with a total value of $660,000.
What is the total value of insider transactions for Verrica Pharmaceuticals (VRCA) in the last 2 years?
According to our estimates, the total value of insider transactions for Verrica Pharmaceuticals in the last 2 years is positive, amounting to $11M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Verrica Pharmaceuticals' market confidence?
Over the last 2 years, insider transactions for Verrica Pharmaceuticals have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
